Literature DB >> 2500889

Vascular involvement in mitochondrial myopathy.

R Sakuta1, I Nonaka.   

Abstract

Electron microscopic examination of muscle specimens taken at biopsy in 6 patients with complex I deficiency and 1 patient with an unknown primary chemical defect who had the clinical characteristics of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) revealed striking abnormalities in blood vessels in 5. Abnormalities consisted of an increased number of enlarged mitochondria with complicated cristae in the pericytes of capillaries, endothelial cells, and smooth muscle cells of the small arteries, including terminal arterioles and precapillary sphincters, predominantly in smooth muscle cells. On statistical analysis, the number of mitochondria and the ratio of mitochondrial area to the total area of the smooth muscle cells were increased approximately tenfold (p less than 0.001). Although stroke-like episodes were not present, similar mitochondrial abnormalities in blood vessels were found in 1 patient who had the encephalomyopathic form of complex IV deficiency and in 2 patients in whom the primary chemical defects could not be clearly defined. Such abnormalities in small arteries might be responsible for the occasional occurrence of transient cerebral ischemia causing stroke-like episodes and progressive mental deterioration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500889     DOI: 10.1002/ana.410250611

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 2.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

3.  Mitochondrial genome: defects, disease, and evolution.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 4.  Clinical and molecular studies of mitochondrial disease.

Authors:  Y Goto
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 5.  Mitochondrial dysfunction in neurological disorders with epileptic phenotypes.

Authors:  Gábor Zsurka; Wolfram S Kunz
Journal:  J Bioenerg Biomembr       Date:  2010-12       Impact factor: 2.945

6.  Mitochondrial encephalomyopathy, lactic acidosis and stroke in adults: two cases.

Authors:  H P Kremer; A Keyser; A R Wintzen; H R Scholte; J G van Hellenberg Hubar; B J Poorthuis; W Ruitenbeek
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

7.  Retinal dystrophy associated with a single-base deletion mutation in mitochondrial DNA 3271 in patient with MELAS syndrome.

Authors:  Kenji Ozawa; Kiyofumi Mochizuki; Yusuke Manabe; Nobuaki Yoshikura; Takayoshi Shimohata; Ichizo Nishino; Yu-Ichi Goto
Journal:  Doc Ophthalmol       Date:  2019-01-30       Impact factor: 2.379

8.  Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis.

Authors:  C M Sue; D S Crimmins; Y S Soo; R Pamphlett; C M Presgrave; N Kotsimbos; M J Jean-Francois; E Byrne; J G Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 9.  Mitochondrial abnormalities in human sural nerves: fine structural evaluation of cases with mitochondrial myopathy, hereditary and non-hereditary neuropathies, and review of the literature.

Authors:  J M Schröder; C Sommer
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Cytochrome c oxidase activity is deficient in blood vessels of patients with myoclonus epilepsy with ragged-red fibers.

Authors:  H Hasegawa; T Matsuoka; Y Goto; I Nonaka
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.